![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Allergan Plc | LSE:0Y7T | London | Ordinary Share | IE00BY9D5467 | ALLERGAN ORD SHS |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 154.21 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDM0Y7T
RNS Number : 5171M
Citadel Group
11 May 2020
Ap 19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Name of person dealing (Note Citadel Group 1) Company dealt in ALLERGAN PLC ------------------------------- Class of relevant security Common Stock ISIN IE00BY9D5467 to which the dealings being ------------------------------ disclosed relate (Note 2) Date of dealing 08 May, 2020 2. INTERESTS AND SHORT POSITIONS (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Common Stock ISIN IE00BY9D5467 Number (%) Number (%) ----------------- ------------- (1) Relevant securities 3,059,488 (0.93%) 3,224 (0.00%) ----------------- ------------- (2) Derivatives (other than options) 3,465,201 (1.05%) 0 (0.00%) ----------------- ------------- (3) Options and agreements to purchase/sell 0 (0.00%) 0 (0.00%) ----------------- ------------- Total 6,524,689(1.98%) 3,224 (0.00%) ----------------- ------------- (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Long Short Number (%) Number (%) ---------- ---------- (1) Relevant securities ---------- ---------- (2) Derivatives (other than options) ---------- ---------- (3) Options and agreements to purchase/sell ---------- ---------- Total ---------- ---------- Ap 20 1. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note Common Stock ISIN IE00BY9D5467 5) Purchase 65 192.15923077 USD -------------------- -------------------- Purchase 10 192.37 USD -------------------- -------------------- Purchase 10 192.38 USD -------------------- -------------------- Purchase 6 192.42 USD -------------------- -------------------- Purchase 126 192.51174603 USD -------------------- -------------------- Purchase 259 192.56942085 USD -------------------- -------------------- Purchase 10 192.61 USD -------------------- -------------------- Purchase 10 192.642 USD -------------------- -------------------- Purchase 50 192.73 USD -------------------- -------------------- Purchase 100 192.93 USD -------------------- -------------------- Sale -15 191.79 USD -------------------- -------------------- Sale -10 192.03 USD -------------------- -------------------- Sale -155 192.13658065 USD -------------------- -------------------- Sale -20 192.19 USD -------------------- -------------------- Sale -20 192.23 USD -------------------- -------------------- Sale -604 192.25013245 USD -------------------- -------------------- Sale -7 192.3 USD -------------------- -------------------- Sale -20 192.35 USD -------------------- -------------------- Sale -216 192.36657407 USD -------------------- -------------------- Sale -44 192.385 USD -------------------- -------------------- Sale -116 192.4 USD -------------------- -------------------- Sale -35 192.40142857 USD -------------------- -------------------- Sale -11 192.43181818 USD -------------------- -------------------- Sale -86 192.43459302 USD -------------------- -------------------- Sale -238 192.45163866 USD -------------------- -------------------- Sale -68 192.46382353 USD -------------------- -------------------- Sale -9 192.5 USD -------------------- -------------------- Sale -134 192.50365672 USD -------------------- -------------------- Sale -100 192.51 USD -------------------- -------------------- Sale -17 192.62470588 USD -------------------- -------------------- Sale -275 192.65872727 USD -------------------- -------------------- Sale -8 192.66875 USD -------------------- -------------------- Sale -37 192.71918919 USD -------------------- -------------------- Sale -337 192.77136499 USD -------------------- -------------------- Sale -67 192.80343284 USD
-------------------- -------------------- Sale -100 192.83 USD -------------------- -------------------- Sale -15 192.83666667 USD -------------------- -------------------- Sale -20 192.84 USD -------------------- -------------------- Sale -22 192.97 USD -------------------- -------------------- Sale -5 193.01 USD -------------------- -------------------- Sale -50 193.0592 USD -------------------- -------------------- Sale -18 193.06277778 USD -------------------- -------------------- Sale -12 193.06833333 USD -------------------- -------------------- Sale -914 193.08 USD -------------------- -------------------- (b) Derivatives transactions (other than options transactions) Product name, Nature of transaction Number of relevant Price per unit e.g. CFD (Note 6) securities (Note 5) ISIN (Note 7) (c) Options transactions in respect of existing relevant securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, Expiry Option money name, e.g. selling, securities price e.g. date paid/ call option purchasing, to which the American, received varying etc. option European per unit relates etc. (Note 5) (Note 7) (ii) Exercising Product name, Number of securities Exercise price per unit e.g. call option (Note 5) (d) Other dealings ( including transactions in respect of new securities) (Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) Ap 21 2. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated None Is a Supplemental Form 8 attached? NO (Note 9) Date of disclosure: 11 May, 2020 Contact name: Katie Bonds ------------- Telephone number: 020 7645 9700 ------------- If a connected EFM, name of offeree/offeror n/a with which connected ------------- If a connected EFM, state nature n/a of connection (Note 10) -------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
ISEBDGDUDGBDGGB
(END) Dow Jones Newswires
May 11, 2020 10:00 ET (14:00 GMT)
1 Year Allergan Chart |
1 Month Allergan Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions